Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A six-gene signature predicting breast cancer lung metastasis.
Landemaine T, Jackson A, Bellahcène A, Rucci N, Sin S, Abad BM, Sierra A, Boudinet A, Guinebretière JM, Ricevuto E, Noguès C, Briffod M, Bièche I, Cherel P, Garcia T, Castronovo V, Teti A, Lidereau R, Driouch K. Landemaine T, et al. Among authors: guinebretiere jm. Cancer Res. 2008 Aug 1;68(15):6092-9. doi: 10.1158/0008-5472.CAN-08-0436. Cancer Res. 2008. PMID: 18676831
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
Bièche I, Chavey C, Andrieu C, Busson M, Vacher S, Le Corre L, Guinebretière JM, Burlinchon S, Lidereau R, Lazennec G. Bièche I, et al. Among authors: guinebretiere jm. Endocr Relat Cancer. 2007 Dec;14(4):1039-52. doi: 10.1677/erc.1.01301. Endocr Relat Cancer. 2007. PMID: 18045955 Free article.
Normal and pathological breast, the histological basis.
Guinebretière JM, Menet E, Tardivon A, Cherel P, Vanel D. Guinebretière JM, et al. Eur J Radiol. 2005 Apr;54(1):6-14. doi: 10.1016/j.ejrad.2004.11.020. Eur J Radiol. 2005. PMID: 15797289 Review.
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.
Hamy AS, Bieche I, Lehmann-Che J, Scott V, Bertheau P, Guinebretière JM, Matthieu MC, Sigal-Zafrani B, Tembo O, Marty M, Asselain B, Spyratos F, de Cremoux P. Hamy AS, et al. Among authors: guinebretiere jm. Breast Cancer Res Treat. 2016 Oct;159(3):499-511. doi: 10.1007/s10549-016-3961-2. Epub 2016 Sep 3. Breast Cancer Res Treat. 2016. PMID: 27592112
Novel indications for BRCA1 screening using individual clinical and morphological features.
Eisinger F, Noguès C, Guinebretière JM, Peyrat JP, Bardou VJ, Noguchi T, Vennin P, Sauvan R, Lidereau R, Birnbaum D, Jacquemier J, Sobol H. Eisinger F, et al. Among authors: guinebretiere jm. Int J Cancer. 1999 Jun 21;84(3):263-7. doi: 10.1002/(sici)1097-0215(19990621)84:3<263::aid-ijc11>3.0.co;2-g. Int J Cancer. 1999. PMID: 10371344
Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers.
Jacquemier J, Eisinger F, Noguès C, Sun ZZ, Guinebretière JM, Peyrat JP, Geneix J, Lidereau R, Birnbaum D, Sobol H. Jacquemier J, et al. Among authors: guinebretiere jm. Int J Cancer. 1999 Sep 24;83(1):45-9. doi: 10.1002/(sici)1097-0215(19990924)83:1<45::aid-ijc9>3.0.co;2-g. Int J Cancer. 1999. PMID: 10449606
Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes.
Meseure D, Vacher S, Drak Alsibai K, Trassard M, Nicolas A, Leclere R, Lerebours F, Guinebretiere JM, Marangoni E, Lidereau R, Bieche I. Meseure D, et al. Among authors: guinebretiere jm. Cancer Microenviron. 2016 Dec;9(2-3):107-118. doi: 10.1007/s12307-016-0186-1. Epub 2016 Jul 9. Cancer Microenviron. 2016. PMID: 27392414 Free PMC article.
139 results